Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, has been recognized for the 11th time as a sustainability leader with inclusion in the Dow Jones Sustainability Index (DJSI Europe).
Fresenius Medical Care North America announced a partnership with Livongo, the leading Applied Health Signals company in the U.S.
Fresenius Medical Care North America and the health insurer Humana are broadening their collaboration.
Fresenius Medical Care, the world’s leading provider of dialysis products and services, has agreed to issue bonds with an aggregate principal amount of USD 1 billion.
Solid revenue growth continued; Significant net income growth; Exceptionally positive free cash flow development; Financial targets for FY2020 confirmed inclusive of anticipated COVID-19 effects
Fresenius Medical Care, the world’s leading provider of dialysis products and services, will hold its Annual General Meeting (AGM) on August 27, 2020 as a virtual event.
